A case of Epstein-Barr virus (EBV)-associated thymic carcinoid and investigation of existence of EBV-infected cells in thymus and thymic tumors

Journal of Clinical Microbiology

Volumn 42, Issue 6, 2004, Pages 2850-2854

  Takeuchi, Hiroaki ^a   Fujita, Hiroshi ^b   Iwasaki, Fumio ^b   Takeuchi, Takako ^c   Imadome, Ken Ichi ^d   Okumiya, Toshika ^e   Matsui, Tomohiro ^f   Takahashi, Mutsuo ^f  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Saiseikai Shimonoseki General Hospital   (Japan)

^c Shimonosekishi ishikai Hospital   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBODY; ANTINEOPLASTIC AGENT; DNA; LACTATE DEHYDROGENASE; PROTEIN P53; RIBONUCLEOPROTEIN; RNA; VIRUS PROTEIN;

AGED; ARTICLE; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE; MALE; METASTASIS; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; THYMOMA; THYMUS; TRANSMISSION ELECTRON MICROSCOPY; TUMOR SUPPRESSOR GENE;

AGED; CARCINOID TUMOR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PARAFFIN EMBEDDING; RNA, VIRAL; THYMUS GLAND; THYMUS NEOPLASMS;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 2942623973     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.6.2850-2854.2004     Document Type: Article

References (28)

1. Ban, S., Y. Goto, K. Kamada, M. Takahama, H. Watanabe, T. Iwahori, and H. Takeuchi. 1999. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Arch. 434:249-254.
2. Borisch, B., T. Kirchner, A. Marx, and H. K. Muller-Hermelink. 1990. Absence of the Epstein-Barr virus genome in the normal thymus, thymic epithelial tumors, thymic lymphoid hyperplasia in a European population. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 59:359-365.
3. Borza, C. M., and L. M. Hutt-Fletcher. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nature Med. 8:594-599.
4. Chan, A. O., S. G. Kim, A. Bedeir, J. P. Issa, S. R. Hamilton, and A. Rashid. 2003. CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22:924-934.
5. Chen, P. C., C. C. Pan, A. H. Yang, L. S. Wang, and H. Chiang. 2002. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J. Pathol. 197:684-688.
6. Chevallier-Greco, A., E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5:3243-3249.
7. Edwards, R. H., and N. Raab-Traub. 1994. Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas. J. Virol. 68:1309-1335.
8. Eliopoulos, A. G., S. M. Blake, J. E. Floettmann, M. Rowe, and L. S. Young. 1999. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J. Virol. 73:1023-1035.
9. Finkelstein, S. D., T. Hasegawa, T. Colby, and S. A. Yousem. 1999. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice. Am. J. Pathol. 155:633-640.
10. Fujimori, M., S. Ikeda, Y. Shimizu, M. Okajima, and T. Asahara. 2001. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res. 61:6656-6659.
11. Gaal, K., L. M. Weiss, W. G. Chen, Y. Y. Chen, and D. A. Arber. 2002. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States. Lab. Investig. 82:957-962.
12. Gilligan, K., P. Rajadurai, L. Resnick, and N. Raab-Traub. 1990. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA 87:8790-8794.
13. Gires, O., F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser, C. Kaiser, R. Zeidler, B. Scheffer, M. Ueffing, and W. Hammerschmidt. 1999. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18:3064-3073.
14. Gugger, M., E. Burckhardt, A. Kappeler, H. Hirsiger, J. A. Laissue, and L. Mazzucchelli. 2002. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J. Pathol. 196:408-415.
15. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479-8483.
16. Inghirami, G., M. Chilosi, and D. M. Knowles. 1990. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. Am. J. Pathol. 136:1429-1436.
17. Kobayashi, R., H. Takeuchi, M. Sasaki, M. Hasegawa, and K. Hirai. 1998. Detection of Epstein-Barr virus infection in the epithelial cells and lymphocytes of non-neoplastic tonsils by in situ hybridization and in situ PCR. Arch. Virol. 143:803-813.
18. Launay, J. M., G. Birraux, D. Bondoux, J. Callebert, D. S. Choi, S. Loric, and L. Maroteaux. 1996. Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J. Biol. Chem. 271:3141-3147.
19. Leyvraz, S., W. Henle, A. P. Chahinian, C. Perlmann, G. Klein, R. E. Gordon, M. Rosenblum, and J. F. Holland. 1985. Association of Epstein-Barr virus with thymic carcinoma. N. Engl. J. Med. 312:1296-1299.
20. Mann, R. B., T. C. Wu, E. M. MacMahon, Y. Ling, P. Charache, and R. F. Ambinder. 1992. In situ localization of Epstein-Barr virus in thymic carcinoma. Mod. Pathol. 5:363-366.
21. McGuire, L. J., D. P. Huang, R. Teoh, M. Arnold, K. Wong, and J. C. Lee. 1988. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am. J. Pathol. 131:385-390.
22. Mitchell, T., and B. Sugden. 1995. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968-2976.
23. Ohshima, K., Q. Liu, T. Koga, J. Suzumiya, and M. Kikuchi. 2002. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma-natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types. Virchows Arch. 440:425-435.
24. Pearson, G. R., J. Luka, L. Petti, J. Sample, M. Birkenbach, D. Braun, and E. Kieff. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151-161.
25. Sagara, M., F. Sugiyama, H. Horiguchi, H. Kamma, T. Ogata, K. Yagami, K. Murakami, and A. Fukamizu. 1995. Activation of the nuclear oncogenes N-myc and c-jun in carcinoid tumors of transgenic mice carrying the human adenovirus type 12 E1 region gene. DNA Cell Biol. 14:95-101.
26. Takeuchi, H., R. Kobayashi, M. Hasegawa, and K. Hirai. 1996. Detection of latent infection by Epstein-Barr virus in peripheral blood cells of healthy individuals and in non-neoplastic tonsillar tissue from patients by reverse transcription-polymerase chain reaction. J. Virol. Methods 58:81-89.
27. Takeuchi, H., R. Kobayashi, M. Hasegawa, and K. Hirai. 1997. Detection of latent Epstein-Barr virus (EBV) DNA in paratin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR. Arch. Virol. 142:1743-1756.
28. Yamamoto, T., Y. Nakamura, K. Kishimoto, H. Takeuchi, M. Shirakata, T. Mitsuya, and K. Hirai. 1999. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1. Virus Res. 65:43-55.